No Data
No Data
Inotiv Completes Hillcrest, UK Expansion, Secures Long-Term Contracts With New Customers
Inotiv, Inc. (NASDAQ:NOTV) (the "Company" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models
Express News | Inotiv Inc: Extension of Maturity Date of $3.7 Mln Obrc Payable Note to July 2025
Express News | Inotiv, Inc. Provides Business Updates
Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating
Craig-Hallum analyst Matt Hewitt maintains $Inotiv(NOTV.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 43.9% and a total average return of -3.8% over the past yea
Lake Street Maintains Inotiv(NOTV.US) With Hold Rating, Maintains Target Price $2
Lake Street analyst Frank Takkinen maintains $Inotiv(NOTV.US)$ with a hold rating, and maintains the target price at $2.According to TipRanks data, the analyst has a success rate of 34.2% and a total
Inotiv to Pay $35M for Canine-Breeding Facility Violations
By Ben Glickman Envigo, a subsidiary of Inotiv, will pay more than $35 million after pleading guilty to animal welfare violations related to a now-shuttered dog breeding facility in Virginia. The Ju